IGF1 and hydrops fetalis: The TOSCA registry revealed that over 90% of HF patients were deficient in at least one anabolic hormone (testosterone, dehydroepiandrosterone sulfate, insulin-like growth factor-I (IGF-I), or triiodothyronine), and more than two-thirds had deficiencies in two or more.